Five-year results of corneal tattooing for cosmetic repair in disfigured eyes

Cornea

Volumn 30, Issue 10, 2011, Pages 1135-1139

  Kim, Cinoo ^a   Kim, Keun Ho ^b   Han, Young Keun ^a   Wee, Won Ryang ^a   Lee, Jin Hak ^a,c   Kwon, Ji Won ^b  

^a Seoul National University   (South Korea)

^b Kwandong University College of Medicine   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

Author keywords

corneal opacity; corneal tattooing; cosmetic repair

Indexed keywords

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLINDNESS; CALCIFICATION; CONTROLLED STUDY; CORNEA OPACITY; CORNEA SURGERY; CORNEAL TATTOOING; DISEASE DURATION; ENUCLEATION; ESTHETIC SURGERY; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; REOPERATION; SEX DIFFERENCE;

ADULT; AGED; ANIMALS; BLINDNESS; COLORING AGENTS; CORNEAL OPACITY; CORNEAL STROMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRAOPERATIVE COMPLICATIONS; MALE; MIDDLE AGED; OPHTHALMOLOGIC SURGICAL PROCEDURES; POSTOPERATIVE COMPLICATIONS; RABBITS; RECONSTRUCTIVE SURGICAL PROCEDURES; RISK FACTORS; TATTOOING; TREATMENT OUTCOME;

EID: 80052764653     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3181f2391a     Document Type: Article

References (40)

1. Coral-Alvarado P, Pardo AL, Castaño-Rodriguez N, et al. Systemic sclerosis: a world wide global analysis. Clin Rheumatol. 2009;28:757-765.
2. Busquets J, Del Galdo F, Kissin EY, et al. Assessment of tissue fibrosis in skin biopsies from patients with systemic sclerosis employing confocal laser scanning microscopy: an objective outcome measure for clinical trials? Rheumatology (Oxford). 2010;49:1069-1075.
3. Czirják L, Foeldvari I, Müller-Ladner U. Skin involvement in systemic sclerosis. Rheumatology (Oxford). 2008;47:44-45.
4. Akinci A, Bulus D, Aycan Z, et al. Central corneal thickness in children with diabetes. J Refract Surg. 2009;25:1041-1044.
5. Evereklioglu C, Madenci E, Bayazit YA, et al. Central corneal thickness is lower in osteogenesis imperfecta and negatively correlates with the presence of blue sclera. Ophthalmic Physiol Opt. 2002;22:511-515. (Pubitemid 41711111)
6. Razeghinejad MR, Safavian H. Central corneal thickness in patients with Weill-Marchesani syndrome. Am J Ophthalmol. 2006;142:507-508. (Pubitemid 44691737)
7. Pesudovs K. Orbscan mapping in Ehlers-Danlos syndrome. J Cataract Refract Surg. 2004;30:1795-1798. (Pubitemid 39094394)
8. Segev F, Héon E, Cole WG, et al. Structural abnormalities of the cornea and lid resulting from collagen V mutations. Invest Ophthalmol Vis Sci. 2006;47:565-573. (Pubitemid 46772886)
9. Heur M, Costin B, Crowe S, et al. The value of keratometry and central corneal thickness measurements in the clinical diagnosis of Marfan syndrome. Am J Ophthalmol. 2008;145:997-1001.
10. Evereklioglu C, Yilmaz K, Bekir NA. Decreased central corneal thickness in children with Down syndrome. J Pediatr Ophthalmol Strabismus. 2002;39:274-277.
11. Cumurcu T, Cumurcu BE, Kilic R, et al. Increased central corneal thickness in children with cerebral palsy. Cornea. 2009;28:375-378.
12. Akinci A, Oner O, Munir K. Central corneal thickness in children with intellectual disability: a controlled study. Cornea. 2010;29:159-161.
13. Evereklioglu C, Er H. Increased corneal thickness in active Behcet's disease. Eur J Ophthalmol. 2002;12:24-29. (Pubitemid 34245818)
14. Sanchis-Gimeno JA, Lleó-Pérez A, Alonso L, et al. Reduced corneal thickness values in postmenopausal women with dry eye. Cornea. 2005; 24:39-44. (Pubitemid 40053493)
15. Jonas JB, Stroux A, Velten I, et al. Central corneal thickness correlated with glaucoma damage and rate of progression. Invest Ophthalmol Vis Sci. 2005;46:1269-1274. (Pubitemid 41685863)
16. Ehlers N, Hjortdal J. Corneal thickness: measurement and implications. Exp Eye Res. 2004;78:543-548. (Pubitemid 38183332)
17. Robert L, Legeais JM, Robert AM, et al. Corneal collagens. Pathol Biol (Paris). 2001;49:353-363. (Pubitemid 32494262)
18. Meek KM, Fullwood NJ. Corneal and scleral collagens-a microscopist's perspective. Micron. 2001;32:261-272.
19. Sii F, Lee GA, Sanfilippo P, et al. Pellucid marginal degeneration and scleroderma. Clin Exp Optom. 2004;87:180-184.
20. Tailor R, Gupta A, Herrick A, et al. Ocular manifestations of scleroderma. Surv Ophthalmol. 2009;54:292-304.
21. Masi AT, Rodnan GP, Medsger TA Jr, et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980;23:581-590. (Pubitemid 10101764)
22. LeRoy EC, Black CM, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15: 202-205. (Pubitemid 18073738)
23. Serup L, Serup J, Hagdrup HK. Increased central cornea thickness in systemic sclerosis. Acta Ophthalmol (Copenh). 1984;62:69-74. (Pubitemid 14191790)
24. Emre S, Kayikcxioǧlu O, Atesx H, et al. Corneal hysteresis, corneal resistance factor, and intraocular pressure measurement in patients with scleroderma using the reichert ocular response analyzer. Cornea. 2010;29:628-631.
25. Shih CY, Graff Zivin JS, Trokel SL, et al. Clinical significance of central corneal thickness in the management of glaucoma. Arch Ophthalmol. 2004;122:1270-1275. (Pubitemid 39180846)
26. Ambrósio R Jr, Klyce SD, Wilson SE. Corneal topographic and pachymetric screening of keratorefractive patients. J Refract Surg. 2003;19:24-29. (Pubitemid 36126021)
27. Allanore Y, Parc C, Monnet D, et al. Increased prevalence of ocular glaucomatous abnormalities in systemic sclerosis. Ann Rheum Dis. 2004; 63:1276-1278. (Pubitemid 39273508)
28. Doughty MJ, Zaman ML. Human corneal thickness and its impact on intraocular pressure measures: a review and meta-analysis approach. Surv Ophthalmol. 2000;44:367-408. (Pubitemid 30151145)
29. Kohlhaas M, Boehm AG, Spoerl E, et al. Effect of central corneal thickness, corneal curvature, and axial length on applanation tonometry. Arch Ophthalmol. 2006;124:471-476.
30. Thomas R, Korah S, Muliyil J. The role of central corneal thickness in the diagnosis of glaucoma. Indian J Ophthalmol. 2000;48:107-111.
31. Christensen A, Narváez J, Zimmerman G. Comparison of central corneal thickness measurements by ultrasound pachymetry, konan noncontact optical pachymetry, and orbscan pachymetry. Cornea. 2008;27:862-865.
32. Panda A, Mohan M, Chawdhary S. Corneal tattooing-experiences with "lamellar pocket procedure". Indian J Ophthalmol. 1984;32:408-411.
33. van der Velden/Samderubun EM, Kok JH. Dermatography as a modern treatment for coloring leucoma corneae. Cornea. 1994; 13: 349-353. (Pubitemid 24198017)
34. Mannis MJ, Eghbali K, Schwab IR. Keratopigmentation: a review of corneal tattooing. Cornea. 1999;18:633-637. (Pubitemid 29522032)
35. Hirsbein D, Gardea E, Brasseur G, et al. [Corneal tattooing for iris defects]. J Fr Ophtalmol. 2008;31:155-164.
36. Khan AO, Meyer D. Corneal tattooing for the treatment of debilitating glare in a child with traumatic iris loss. Am J Ophthalmol. 2005;139:920-921. (Pubitemid 40614786)
37. Remky A, Redbrake C, Wenzel M. Intrastromal corneal tattooing for iris defects. J Cataract Refract Surg. 1998;24:1285-1287. (Pubitemid 28473545)
38. Ahn SJ, Han YK, Kwon JW. A case of superficial corneal tattooing for glare after trabeculectomy. Can J Ophthalmol. 2009;44:e63.
39. Stone NM, Somner JE, Jay JL. Intractable diplopia: a new indication for corneal tattooing. Br J Ophthalmol. 2008;92:1445, 561-562.
40. Wiegmann E. Is tattooing according to Knapp entirely without danger? Am J Ophthalmol. 1999;18:633-637.